Bayer’s stock is jumping on secondary stroke drug’s trial success

by | Nov 24, 2025 | Uncategorized

Spread the love
Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments